For the quarter ending 2025-06-30, DRRX made $447K in revenue. -$2,265K in net income. Net profit margin of -506.71%.
| Income Statement | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
| Total revenues | 447 | 321 | 35 | 1,927 |
| Selling, general and administrative | 2,067 | 2,577 | 2,422 | 3,217 |
| Research and development | 1,176 | 1,883 | 2,740 | 2,164 |
| Cost of product revenues | 7 | - | -145 | 513 |
| Total operating expenses | 3,250 | 4,460 | 5,016 | 5,894 |
| Loss from operations | -2,803 | -4,139 | -4,982 | -3,967 |
| Interest and other expenses | - | - | - | 364 |
| Interest and other income | 93 | 95 | 219 | 163 |
| Change in fair value of warrant liabilities | -445 | 119 | 190 | 117 |
| Other income (expense), net | 538 | -24 | 272 | -318 |
| Loss from continuing operations | -2,265 | -4,163 | -4,603 | - |
| Income (loss) from discontinued operations | - | -69 | 3,258 | - |
| Net loss | -2,265 | -4,232 | -1,346 | -4,285 |
| Net change in unrealized loss on available-for-sale securities, net of reclassification adjustments and taxes | - | - | 2 | 7 |
| Total comprehensive loss | -2,265 | -4,232 | -1,344 | -4,278 |
| Net loss per share - basic | -0.07 | -0.13 | -0.043 | -0.14 |
| Net loss per share - diluted | -0.07 | -0.13 | -0.043 | -0.14 |
| Weighted average number of shares outstanding - basic | 31,042,000 | 31,042,000 | -33,000 | 31,039,000 |
| Weighted average shares used to compute diluted net loss per share | 31,163,000 | 31,042,000 | -33,000 | 31,039,000 |
DURECT CORP (DRRX)
DURECT CORP (DRRX)